Value of PET/MRI for assessing tumor resectability in NSCLC - intra-individual comparison with PET/CT.
CONCLUSIONS: In NSCLC the use of PET/MRI, including a dedicated pulmonary MR imaging protocol, provides a comparable diagnostic value for determination of tumor resectability compared to PET/CT. Advances in knowledge: Our findings suggest that whole body PET/MRI can safely be used for the local staging of NSCLC patients. Further studies are warranted to determine whether it is feasible to integrate an imaging sequence in a whole body PET/MRI setting with the potential advantage of detection of liver or brain metastases.
PMID: 30209954 [PubMed - as supplied by publisher]
Source: The British Journal of Radiology - Category: Radiology Authors: Messerli M, Barbosa F, Marcon M, Muehlematter UJ, Stolzmann P, Warschkow R, Delso G, Ter Voert EE, Huellner MW, Frauenfelder T, Veit-Heibach P Tags: Br J Radiol Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Liver | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | PET Scan | Radiology | Study | UK Health | Urology & Nephrology